Plasma biomarkers for mild cognitive impairment and Alzheimer's disease

F Song, A Poljak, GA Smythe, P Sachdev - Brain research reviews, 2009 - Elsevier
Purpose of review: With the move toward development of disease modifying treatments,
there is a need for more specific diagnosis of early Alzheimer's disease (AD) and mild …

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

M Bettinetti‐Luque, L Trujillo‐Estrada… - British Journal of …, 2024 - Wiley Online Library
Adipose tissue has recently been recognized as an important endocrine organ that plays a
crucial role in energy metabolism and in the immune response in many metabolic tissues …

Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment

M Elahy, C Jackaman, JCL Mamo, V Lam… - Immunity & …, 2015 - Springer
Background Functional loss of blood–brain barrier (BBB) is suggested to be pivotal to
pathogenesis and pathology of vascular-based neurodegenerative disorders such as …

Plasma proteins predict conversion to dementia from prodromal disease

A Hye, J Riddoch‐Contreras, AL Baird… - Alzheimer's & …, 2014 - Wiley Online Library
Background The study aimed to validate previously discovered plasma biomarkers
associated with AD, using a design based on imaging measures as surrogate for disease …

Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease

Y Zhao, CY Zeng, XH Li, TT Yang, X Kuang, JR Du - Aging Cell, 2020 - Wiley Online Library
Alzheimer's disease (AD) is the most prevalent type of dementia, characterized by the
presence of amyloid‐β (Aβ) plaques. We previously reported that Klotho lowered Aβ levels …

Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link

R Takechi, V Lam, E Brook, C Giles… - Frontiers in aging …, 2017 - frontiersin.org
Diabetic insulin resistance and pro-diabetic diet are reported to increase dementia risk
through unknown mechanisms. Emerging evidence suggests that the integrity of blood-brain …

Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals

F Song, A Poljak, J Crawford, NA Kochan, W Wen… - PloS one, 2012 - journals.plos.org
Objectives Apolipoproteins have recently been implicated in the etiology of Alzheimer's
disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a …

Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice

NF Fitz, A Cronican, T Pham, A Fogg… - Journal of …, 2010 - Soc Neuroscience
High-fat diet and certain dietary patterns are associated with higher incidence of sporadic
Alzheimer's disease (AD) and cognitive decline. However, no specific therapy has been …

Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer's …

O Busquets, M Ettcheto, M Pallàs, C Beas-Zarate… - Mechanisms of ageing …, 2017 - Elsevier
Aims The sporadic and late-onset form of Alzheimer's disease (AD) constitutes the most
common form of dementia. This non-familiar form could be a consequence of metabolic …

Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotype

V Lam, R Takechi, MJ Hackett, R Francis… - PLoS …, 2021 - journals.plos.org
Several lines of study suggest that peripheral metabolism of amyloid beta (Aß) is associated
with risk for Alzheimer disease (AD). In blood, greater than 90% of Aß is complexed as an …